Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: techmover, Penny Traders Club, Top Penny, bz777, UndervaluedStocks, whento
Search This Board: 
Last Post: 8/17/2017 10:26:35 PM - Followers: 443 - Board type: Free - Posts Today: 76



ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer. Sales of its microarray products are in excess of $30,000 to $40,000 per day!! Please research this Silicon Valley company. This company has potential of trading in excess of $5 per share:


Follow  @Arrayit and $ARYC on Twitter


Arrayit Corporation on Facebook 


No share increase per CEO.....!!!!!..  AND......Trading at .6x earnings....... Yes, point 6 times!

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 


Trading at an incredibly low share price under a penny.


2 contracts signed last year for a total of approximately $51 million over the next 3 years ......


No other sub penny company has the potential of ARYC  


Please check out their tweets @Arrayit or go to their Facebook page: Arrayit Corporation 




Please check their products that are selling in the tens of thousands of dollars daily. 


Link to their products:


Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities.


ARYC is continuing  a strong and steady move up on steady  volume.  Please take some time to review the ARYC board with due diligence done by investors.



Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA 

(link: ;… 


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.


ARYC: Arrayit Corporation 


@Arrayit on Twitter 


Link to their products:


ARYC also owns 40 million shares of AVDX. A value of $12 million +


Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.


$ARYC.....Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the
Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection



About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#51900  Sticky Note Last summarised ARYC_microarray_business_reports from May - July 2017 HighYieldStocks 07/29/17 03:01:07 PM
#49456  Sticky Note Attention all new investors in ARYC!! whento 07/12/17 10:40:46 PM
#47743  Sticky Note Ladies and Gentlemen, as incredulous as it may spotlight1 06/29/17 01:44:26 PM
#46478  Sticky Note We expect an immediate share price increase upon techmover 05/25/17 05:24:04 PM
#42929  Sticky Note ***Ten Reasons To Invest in Arrayit Corporation (ARYC)*** Penny Traders Club 04/01/17 11:54:57 AM
#53641   This sums up ARYC just about perfectly! nobodysmoney 08/17/17 10:26:35 PM
#53640   ARYC prime take over target and imo they Meq 08/17/17 09:52:38 PM
#53639   Great post PJ ...thanks UndervaluedStocks 08/17/17 09:05:50 PM
#53637   Gotta love when you are bidding on .008 Sendme 08/17/17 08:39:53 PM
#53635   Load up now before financials are released! Great Toofast 08/17/17 07:15:56 PM
#53632   GREAT POST, MY FRIEND...YOU NAILED IT...PATIENCE IS GETTING HighYieldStocks 08/17/17 04:27:10 PM
#53625   There is probably last chance to sell before Hugie 08/17/17 03:22:30 PM
#53624   Well I am not. But thanks! HotStockAlerts 08/17/17 03:12:19 PM
#53623   Not sure why this makes your day! rh22 08/17/17 03:11:37 PM
#53622   Aryc is probably in bankruptcy without money.Expect just Hugie 08/17/17 03:08:04 PM
#53621   Quite likely, if filings don't hit, it will Full Contact Yoga 08/17/17 02:57:33 PM
#53619   Well, being down 60% from it's hyped high jrsh 08/17/17 02:14:29 PM
#53618   I have personally called ARYC at least 6 times. rh22 08/17/17 02:07:09 PM
#53617   $$$$ARYC $$$ bought 80 more 1230034 now okwife 08/17/17 02:01:33 PM
#53615   Wish I had more cap reserve to load Cayman75 08/17/17 01:27:26 PM
#53614   This is going back to 0,0004 as this Hugie 08/17/17 01:24:42 PM
#53613   Certainly won't help them, but they've lied in Full Contact Yoga 08/17/17 01:22:24 PM
#53612   This SCAM probably pumped the stock to sell shares. Hugie 08/17/17 01:20:49 PM
#53611   IF they really fail those AUDIT COMPLETION tweets jrsh 08/17/17 01:17:36 PM
#53610   Locked and loaded!!! Aryc Godsnunba1 08/17/17 01:16:37 PM
#53609   Just load up @.0085 crazy! We are going Cayman75 08/17/17 01:15:42 PM
#53608   Load up now before financials come! By the Toofast 08/17/17 01:12:25 PM
#53607   How long will you keep saying the financials nobodysmoney 08/17/17 01:00:07 PM
#53606   I should have stayed with my prediction in Dixmoor 08/17/17 12:47:44 PM
#53605   They will not release it.Suspension is coming first.. Hugie 08/17/17 12:45:08 PM
#53604   Load up now before the financials come! Big Toofast 08/17/17 12:41:07 PM
#53603   Manipulation Penny Traders Club 08/17/17 12:39:05 PM
#53602   You got jokes right? What, fins? bmo810 08/17/17 12:38:09 PM
#53601   Really lol ARYC$$ Meq 08/17/17 12:37:15 PM
#53600   Big news coming soon. Load up HotStockAlerts 08/17/17 12:24:03 PM
#53599   NEW tweet...Arrayit reports $8,800 microarray technology quote to HighYieldStocks 08/17/17 12:18:49 PM
#53598   They're well aware I'm sure, they've lied and Full Contact Yoga 08/17/17 12:17:57 PM
#53597   It's great to have a mentor BUT..... are ScorpGirl 08/17/17 12:14:36 PM
#53596   NEW tweet...Arrayit reports microarray technology inquiry from top HighYieldStocks 08/17/17 12:00:29 PM
#53595   NEW tweet...Arrayit president Dr Mark Schena's mentor Dr HighYieldStocks 08/17/17 11:48:06 AM
#53592   NEW tweet...Arrayit reports microarray manufacturing inquiry from HighYieldStocks 08/17/17 11:40:23 AM
#53591   NEW tweet...Arrayit bioinformatics team invited to international B HighYieldStocks 08/17/17 11:40:11 AM
#53590   NEW tweet...Arrayit quotes $23,945 microarray technology platform HighYieldStocks 08/17/17 11:39:57 AM
#53589   Even SCAM as ARYC can run but you Hugie 08/17/17 11:32:38 AM
#53588   SKULL AND CROSSBONES FOR ARYC lucky,mydog 08/17/17 11:29:13 AM
#53587   Good luck to you on that. techmover 08/17/17 11:27:57 AM
#53585   TO REPORT ARYC..... for continued delinquency......... lucky,mydog 08/17/17 11:01:18 AM
#53583   So many fake tweets about the fins. Hugie 08/17/17 10:57:16 AM
#53582   Yeah right. Have you even talked in person techmover 08/17/17 10:51:28 AM
#53581   this piece of crap is no start up. lucky,mydog 08/17/17 10:50:13 AM
#53580   Oh you must be talking about Walmart and techmover 08/17/17 10:49:28 AM
#53579   Most CEOs hate talking in person because they're lucky,mydog 08/17/17 10:47:16 AM
#53578   So after waiting April already for the fins jrsh 08/17/17 10:32:10 AM
#53577  Restored back under a penny. still priced way to lucky,mydog 08/17/17 10:26:15 AM
#53576   I wonder how much shares Trump fam hold jdemuss 08/17/17 10:10:53 AM